This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Brinzolamide 10 mg/ml eye drops, Suspension PA2315/149/001 Accord Healthcare Ireland Ltd. | Brinzolamide |
| Dutasteride/Tamsulosin hydrochloride Pinewood 0.5mg/0.4mg Hard Capsules PA0281/216/001 Pinewood Laboratories Ltd | Tamsulosin & dutasteride |
| Faverin 100 mg film-coated tablets PA23355/024/002 Viatris Healthcare Limited | Fluvoxamine |
| Gemcitabine Teva 40mg/ml Concentrate for Solution for Infusion (25ml presentation) PA1986/122/001 Teva | Gemcitabine |
| Gemcitabine Teva 40mg/ml Concentrate for Solution for Infusion (50ml presentation) PA1986/122/001 Teva | Gemcitabine |
| Germentin 250 mg/125 mg Film-coated Tablets PA23266/015/003 Viatris Limited | Amoxicillin & clavulanic acid |
| Granpidam EU/1/16/1137/001-005 Accord Healthcare S.L.U. | Sildenafil base (as citrate) |
| Icatibant Accord 30 mg solution for injection in pre-filled syringe EU/1/21/1567/001-002 Accord Healthcare S.L.U. | Icatibant |
| Metalyse 50mg Powder and Solvent for Solution for Injection EU/1/00/169/006 Boehringer Ingelheim International GmbH | Tenecteplase |
| Polivy Powder for Concentrate for Solution for Infusion (140mg presentation) EU/1/19/1388/001 Roche Registration GmbH | Polatuzumab vedotin |
| Rasagiline Accord 1 mg tablets PA2315/174/001 Accord Healthcare Ireland Ltd. | Rasagiline |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Aripiprazole Teva 10 mg tablets PA1986/019/002 Teva B.V. | Aripiprazole |
| Beclazone 100 micrograms CFC-Free Inhaler Pressurised Inhalation Solution PA0436/021/010 Norton Waterford | Beclometasone |
| Effentora 100 microgram Buccal tablet EU/1/08/441/1-2 Teva B.V. | Fentanyl |
| Effentora 400 microgram Buccal tablet EU/1/08/441/5-6 Teva B.V. | Fentanyl |
| Etoricoxib Teva 90 mg film-coated tablets PA1986/002/003 Teva B.V. | Etoricoxib |
| Nimbex 2mg/ml solution for injection/infusion PA1691/030/001 Aspen Pharma Trading Limited | Cisatracurium |
| Priligy 30 mg film-coated tablets PA1833/001/001 A. Menarini Pharmaceuticals Ireland Ltd | Dapoxetine |
| Subutex 8 mg sublingual Tablets PA22617/001/003 Indivior Europe Limited | Buprenorphine |
| Targocid 400mg Powder and Solvent for Solution for Injection/infusion or oral solution PA0540/021/002 Sanofi-Aventis Ireland Limited T/A SANOFI | Teicoplanin |
| Ultiva 2 mg Powder for Concentrate for Solution for Infusion PA1691/032/002 Aspen Pharma Trading Limited | Remifentanil |
| Ultiva 5 mg Powder for Concentrate for Solution for Infusion PA1691/032/003 Aspen Pharma Trading Limited | Remifentanil |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.